Fresenius Medical Care AG

BRSE:FME Stock Report

Market Cap: CHF11.2b

Fresenius Medical Care Valuation

Is FME undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FME when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FME (CHF36.89) is trading below our estimate of fair value (CHF130.03)

Significantly Below Fair Value: FME is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FME?

Other financial metrics that can be useful for relative valuation.

FME key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.2x
Enterprise Value/EBITDA9.8x
PEG Ratio1.1x

Price to Earnings Ratio vs Peers

How does FME's PE Ratio compare to its peers?

The above table shows the PE ratio for FME vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average46.5x
GALE Galenica
21.3x5.2%CHF3.5b
SOON Sonova Holding
26.1x10.7%CHF15.7b
STMN Straumann Holding
75.7x20.9%CHF18.6b
YPSN Ypsomed Holding
62.9x16.0%CHF4.6b
FME Fresenius Medical Care
23.1x20.9%CHF11.5b

Price-To-Earnings vs Peers: FME is good value based on its Price-To-Earnings Ratio (23.1x) compared to the peer average (46.5x).

Price to Earnings Ratio vs Industry

How does FME's PE Ratio compare vs other companies in the European Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.1%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.1%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: FME is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the European Healthcare industry average (17.9x).

Price to Earnings Ratio vs Fair Ratio

What is FME's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FME PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate FME's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst FME forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF36.89
CHF38.16
+3.5%
18.5%CHF57.01CHF25.34n/a19
Apr ’25n/a
CHF37.90
0%
19.2%CHF56.91CHF25.29n/a19
Mar ’25n/a
CHF39.02
0%
25.8%CHF69.77CHF24.85n/a20
Feb ’25CHF34.25
CHF37.93
+10.7%
25.8%CHF66.19CHF22.38n/a20
Jan ’25n/a
CHF39.72
0%
26.1%CHF67.39CHF22.78n/a19
Dec ’24CHF35.82
CHF39.93
+11.5%
26.0%CHF67.66CHF22.87n/a19
Nov ’24n/a
CHF41.07
0%
21.6%CHF57.04CHF22.81n/a18
Oct ’24CHF40.60
CHF42.84
+5.5%
22.3%CHF64.25CHF23.02n/a18
Sep ’24n/a
CHF42.59
0%
22.3%CHF64.12CHF22.97n/a19
Aug ’24n/a
CHF39.24
0%
27.3%CHF64.25CHF20.14n/a18
Jul ’24n/a
CHF37.27
0%
27.9%CHF65.44CHF20.51n/a17
Jun ’24n/a
CHF36.02
0%
31.2%CHF65.24CHF16.94n/a17
May ’24n/a
CHF35.36
0%
32.2%CHF65.99CHF17.14CHF36.8916
Apr ’24n/a
CHF33.41
0%
33.2%CHF65.68CHF17.06n/a16
Mar ’24n/a
CHF33.27
0%
34.9%CHF66.76CHF17.34n/a15
Feb ’24n/a
CHF32.63
0%
36.0%CHF66.68CHF17.02CHF34.2515
Jan ’24n/a
CHF33.65
0%
33.3%CHF66.08CHF16.86n/a15
Dec ’23n/a
CHF33.76
0%
34.3%CHF66.00CHF16.84CHF35.8214
Nov ’23n/a
CHF36.91
0%
32.1%CHF66.19CHF16.89n/a15
Oct ’23n/a
CHF43.86
0%
24.9%CHF65.03CHF22.33CHF40.6014
Sep ’23n/a
CHF45.23
0%
24.9%CHF64.78CHF22.24n/a14
Aug ’23n/a
CHF55.47
0%
22.3%CHF74.58CHF22.37n/a15
Jul ’23n/a
CHF65.99
0%
12.4%CHF83.10CHF51.56n/a15
Jun ’23n/a
CHF67.36
0%
13.1%CHF86.17CHF53.46n/a16
May ’23n/a
CHF66.78
0%
13.3%CHF85.67CHF50.03n/a16

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.